Related to TAP, Open University to Develop 3-D CNS Tissue Models for Research, Drug Testing

• Evotec and Merck KGaA Sign Neurological Drug Discovery Deal
  
• LGC Signs Up as First Distributor for Reinnervate’s 3-D Cell Culture Scaffold
  
• Cell Trends and Texcell Couple Biotherapeutic Safety Testing Services
  
• Cisbio Bioassays and Functional Genomics Institute Initiate Drug Discovery Program for CNS Diseases
  
• Takeda Snags Exclusive License to Baxter’s Vero Cell Culture Tech for Flu Vaccine
  
• Amsterdam Molecular Therapeutics Gains Additional Rights to Amgen GDNF Gene
  
• Cephalon Shells Out $350M to Commercialize Mesoblast Stem Cell Therapies
  
• Shrink and EV Group Partner to Develop and Manufacture Nanotech StemDisc Products
  
• Cypress Finally Agrees to $255M, $6.50 per Share Acquisition by Ramius and Royalty Pharma
  
• Biogen Idec Picks Up Neurimmune's Neurodegenerative Programs for $32.5M
  
• Merck KGaA Buys Chinese Cell Culture Media Firm Beijing Skywing for About $18.8M
  
• Biocartis Signs Assay Deal for Its MDx Platform with Janssen Pharmaceutica
  
• Biotie to Acquire CNS Therapeutics Firm Synosia in €93.6M All-Shares Deal
  
• Scripps and UPenn Researchers Awarded $8M to Develop Drugs for Tobacco Addiction
  
• Complete Genomics to Sequence Genomes for ISB Neurodegenerative Study
  
• Hamilton Provides UNC with Integrated Compound Storage and Screening System
  
• Animal-Free Culture System for Single-Cell Passaging of hESCs Developed
  
• Researchers Develop Method to Study Transiently Folded Proteins
  
• KineMed’s Neurogenesis Technology Added to PsychoGenics’ Platform for CNS Drug Discovery
  
• Généthon and Wake Forest Partner on Preclinical Gene Therapy for Myotubular Myopathy